TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļTMDX
āļāļ·āđāļāļāļĢāļīāļĐāļąāļTransmedics Group Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 02, 2019
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ2018
āļāļĩāļāļĩāđāļDr. Waleed H. Hassanein, M.D.
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ728
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 02
āļāļĩāđāļāļĒāļđāđ200 Minuteman Road
āđāļĄāļ·āļāļANDOVER
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ Global Market Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ01810
āđāļāļĢāļĻāļąāļāļāđ19785520900
āđāļ§āđāļāđāļāļāđhttps://www.transmedics.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļTMDX
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 02, 2019
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ2018
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
Dr. David Weill, M.D.
Independent Director
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
Ms. Merilee Raines, CPA
Independent Director
Ms. Stephanie Lovell
Independent Director
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Mr. Anil Ranganath
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
Mr. Edwin M. Kania, Jr.
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
Dr. David Weill, M.D.
Independent Director
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
Ms. Merilee Raines, CPA
Independent Director
Ms. Stephanie Lovell
Independent Director
Invesco Dorsey Wright Healthcare Momentum ETF
Invesco S&P SmallCap Health Care ETF
Innovator IBD 50 Fund ETF
SPDR S&P Health Care Equipment ETF
Invesco S&P SmallCap 600 Pure Growth ETF
First Trust Nasdaq Lux Digi Health Solutions ETF
Fidelity Sustainable US Equity ETF
BNY Mellon Innovators ETF
WisdomTree US SmallCap Quality Growth Fund
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Global X HealthTech ETF
āļŠāļąāļāļŠāđāļ§āļ4.45%
Invesco Dorsey Wright Healthcare Momentum ETF
āļŠāļąāļāļŠāđāļ§āļ3.43%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ3.24%
Innovator IBD 50 Fund ETF
āļŠāļąāļāļŠāđāļ§āļ3.1%
SPDR S&P Health Care Equipment ETF
āļŠāļąāļāļŠāđāļ§āļ1.71%
Invesco S&P SmallCap 600 Pure Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.53%
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļāļŠāđāļ§āļ1.51%
Fidelity Sustainable US Equity ETF
āļŠāļąāļāļŠāđāļ§āļ1.25%
BNY Mellon Innovators ETF
āļŠāļąāļāļŠāđāļ§āļ1.12%
WisdomTree US SmallCap Quality Growth Fund
āļŠāļąāļāļŠāđāļ§āļ0.73%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ